Onwu Daniel Ocha | Drug Discovery | Best Researcher Award

Best Researcher Award

Onwu, Daniel Ocha
Affiliation University of Cross River State
Country Nigeria
Google Scholar ID n6jcvPsAAAAJ
Documents 9
Citations 2
h-index 1
Subject Area Drug Discovery
Event International Top Pharmaceutical Awards

Onwu Daniel Ocha – University of Cross River State

Onwu Daniel Ocha is a researcher affiliated with the University of Cross River State (UNICROSS), Calabar, Nigeria. His reported scholarly work is associated with computational biology, bioinformatics, drug discovery, network pharmacology, phytochemical investigation, and computational modelling. The supplied Google Scholar record reports nine documents, two citations, and an h-index of one. The profile also identifies computational biology and bioinformatics among the research areas associated with his scholarly activity.

Abstract

Onwu Daniel Ocha’s research profile reflects interdisciplinary activity connecting computational biology and bioinformatics with pharmaceutical and biomedical investigation. His available publication record includes research on phytochemicals, network pharmacology, computational modelling, biological targets, infectious diseases, and therapeutic investigation. These subjects are relevant to modern drug discovery because computational approaches can support the identification of candidate compounds, molecular targets, pathways, and potential mechanisms of action. His research record therefore demonstrates an emerging connection between computational science and pharmaceutical research. [1]

Keywords

Drug Discovery; Computational Biology; Bioinformatics; Network Pharmacology; Computational Modelling; Molecular Docking; Phytochemicals; Drug Target Identification; Systems Biology; Therapeutic Targeting; Pharmaceutical Research; In-silico Research; Biomedical Informatics.

Introduction

Computational biology and bioinformatics have become important components of modern pharmaceutical research. Computational approaches can be used to examine molecular interactions, biological pathways, disease-associated targets, and candidate therapeutic compounds before or alongside laboratory validation. Network pharmacology is particularly useful for studying complex relationships between compounds, proteins, pathways, and disease mechanisms. These approaches can contribute to the prioritization of potential therapeutic candidates and provide hypotheses for subsequent experimental research [1].

Research Profile

The supplied academic profile identifies Onwu Daniel Ocha with the University of Cross River State (UNICROSS), Calabar, Nigeria. His Google Scholar record reports nine documents, two citations, and an h-index of one. The research areas represented in the supplied profile include computational biology and bioinformatics, while the award profile specifically identifies Drug Discovery as the subject area. This combination places his research at the intersection of computational science and pharmaceutical investigation.[3]

Research Contributions

A notable contribution in the supplied publication record is the study titled In-Silico and Network Pharmacology Analysis of Mimosa invisa Phytochemicals against Testicular Inflammation. The work examines phytochemical compounds using computational approaches to investigate their potential relationships with inflammation-associated biological targets. This research direction is relevant to drug discovery because phytochemicals may provide candidate structures for further pharmacological investigation [3].

Publications

The available publication record demonstrates continuing scholarly activity in computational and biomedical research. Listed publications include studies on Mimosa invisa phytochemicals, biosynthesized silver nanoparticles, Terminalia catappa extracts, Allium cepa bioactive compounds, drug-resistant tuberculosis, Tefairia occidentalis phytocompounds, and computational analysis of antiviral targets. The diversity of these topics indicates an interdisciplinary research approach involving computational methods and biological investigation.[3].

Research Impact

The supplied Google Scholar profile reports two citations and an h-index of one. These bibliometric indicators represent the citation activity recorded by the profile at the time of the supplied document and may change as additional publications are indexed and cited. Therefore, citation indicators should be considered together with publication quality, research relevance, collaboration, and scientific contribution when assessing an emerging researcher.[4].

Award Suitability

The award assessment should nevertheless remain evidence-based and should consider the complete research portfolio, verified publication records, originality, methodological quality, scholarly contribution, collaboration, and the official eligibility criteria established by the award organizers. The available profile demonstrates an emerging publication record rather than providing sufficient evidence for unsupported claims of exceptional impact. This distinction maintains a neutral academic approach to recognition[4].

Conclusion

Onwu Daniel Ocha’s documented research profile demonstrates interdisciplinary activity involving computational biology, bioinformatics, drug discovery, network pharmacology, phytochemicals, and systems biology. The supplied record identifies nine documents, two citations, and an h-index of one, while the listed publications demonstrate research activity across several biomedical and pharmaceutical themes. [1].

References

  1. Onwu, D. O., Uraku, O. H., Agbi, M. T., & Uraku, A. J. (2026). In-silico and network pharmacology analysis of Mimosa invisa phytochemicals against testicular inflammation. In Silico Research in Biomedicine, 2, 100274.
    https://doi.org/10.1016/j.insi.2026.100274
  2. Onwu, D., Edun, S., Asuquo, U., & Bajepade, T. I. (2025). Antidiabetic potential of biosynthesized silver nanoparticles with fresh guava leaf. Covenant Journal of Physical and Life Sciences, 13(2), 1–6.
    https://journals.covenantuniversity.edu.ng/index.php/cjpls/article/view/4978
  3. Onwu, D. O., Kayode, D., Oluwatosin, C. E., Chimaobi, N. G., Johnson, O., et al. (2026). Assessing the effects of aqueous extract of Terminalia catappa on immunoglobulins levels in cyclophosphamide induced immunosuppressant Wistar rats. Next Research, 101441.
    https://doi.org/10.1016/j.nexres.2026.101441
  4. Onwu, D. O., Singh, A., Bajpai, Y., Akinlamilo, A. S., Habiganuchi, A., & Ibikunle, F. O. (2025). Host–pathogen interaction mapping in drug-resistant tuberculosis: A systems biology framework for dual therapeutic targeting. Research Square.
    https://doi.org/10.21203/rs.3.rs-7855974/v1
  5. Ahmad, A., Nnenna, A. O., Mamman, S., Nwokoro, C., Bello, A. M., Nseabasi, M. A., Abdulwakiil, M., Okpe, J., Onwu, D. O., Agbi, M., & Idoko, A. (2025). In-silico network pharmacology and computational modelling of bioactive compounds from Allium cepa targeting downstream protein effectors in diabetes. Research Square.
    https://doi.org/10.21203/rs.3.rs-8181479/v1

Dipanjan Karati | Drug Discovery and Development | Best Researcher Award

Dipanjan Karati | Drug Discovery and Development | Best Researcher Award

Dr Dipanjan Karati, Techno India University, West Bengal, India

Dr. Dipanjan Karati is an Assistant Professor at Techno India University, West Bengal, with expertise in pharmaceutical chemistry. He holds a M. Pharm (2021) from Bharati Vidyapeeth University and a B. Pharm (2019) from MAKAUT, both with distinction. His research focuses on neurodegenerative diseases and antimicrobial agents, with several publications in prestigious journals. Dr. Karati has actively participated in numerous seminars, webinars, and workshops. He is a GPAT 2019 qualifier and has industrial training at Glenmark Pharmaceuticals. He is passionate about academics and research in the field of drug development. 📚💊🧠🔬👨‍🔬

Publication Profile

Google Scholar

Academic Excellence

Dr. Dipanjan Karati is a highly qualified pharmaceutical professional with a strong academic background. He completed his M. Pharm in Pharmaceutical Chemistry from Poona College of Pharmacy, Bharati Vidyapeeth University, Pune, in 2021, securing a first-class distinction with an 8.09 CGPA. Prior to that, he earned his B Pharm from NSHM Knowledge Campus, Kolkata, in 2019, with an outstanding 80.2% (1st class with distinction). Dr. Karati completed his HSC in 2013 with 81.2% and SSC in 2011 with 78.125% from Garh Bhawanipur RP Institution, Howrah. His consistent academic performance highlights his dedication to the pharmaceutical field. 📚💊🎓

Research Project

Dr. Dipanjan Karati’s research focuses on the “In Silico Design, Synthesis, and Evaluation of Novel Schiff Base Congeners as Neurodegenerative and Antimicrobial Agents.” His objective is to design and synthesize innovative pyrimidine derivatives containing a nitrile group and substituted Schiff bases with azomethine groups. These compounds are being explored for their potential in treating neurodegenerative diseases and exhibiting antimicrobial properties. Dr. Karati’s work combines advanced computational techniques and experimental synthesis to develop effective therapeutic agents, aiming to contribute significantly to the fields of neurodegenerative diseases and antimicrobial resistance. 🔬🧠💊🦠💡

Experience

Dr. Dipanjan Karati has an impressive academic and professional background in the pharmaceutical field. He completed his Industrial Training at Glenmark Pharmaceutical Limited from January 9th to 23rd, 2018, gaining valuable industry experience. He served as an Assistant Professor at Gitanjali College of Pharmacy in Lohapur, Birbhum, for one year, contributing to the academic development of students. Currently, Dr. Karati holds the position of Assistant Professor at the School of Pharmacy, TIU, since September 2022, continuing his dedication to education and research. 📚💊👨‍🏫

Achievements and Awards

Dr. Dipanjan Karati achieved a significant milestone by qualifying for the All India Graduate Pharmacy Aptitude Test (GPAT) in 2019, showcasing his dedication and expertise in the field of pharmacy. 🏆📚 This prestigious achievement highlights his academic excellence and potential for contributing to pharmaceutical sciences. 🌟💊 With his strong foundation and passion for research, Dr. Karati is committed to advancing innovations in pharmacy and healthcare. 🚀🔬 His GPAT qualification is a testament to his hard work and determination, inspiring others in the field to strive for academic and professional success. 🌱🎓

Research Focus

Dr. Dipanjan Karati’s research focuses on medicinal chemistry, pharmacognosy, and drug discovery. His studies emphasize exploring bioactive compounds from plants 🌱, such as Ficus racemosa and Zingiber officinale, for their pharmacological properties including anti-inflammatory, anticancer, and antimicrobial activities 🧪🩺. He investigates synthetic scaffolds like pyrazoles and benzimidazoles for designing innovative therapies targeting diseases such as cancer, malaria, and infections 🎯🧬. Dr. Karati also explores bio-responsive polymers for targeted drug delivery and examines natural products like Cordyceps sinensis for therapeutic potential 🍄🔬. His work bridges natural products and modern medicinal approaches, advancing personalized treatments 🌟📖.

Publication Top Notes

Alkylating agents, the road less traversed, changing anticancer therapy

Pyrazole Scaffolds: centrality in anti-inflammatory and antiviral drug design

Exploring the pharmacognostic properties and pharmacological activities of phytocompounds present in Ficus racemosa linn.: A concise review

A molecular insight into pyrazole congeners as antimicrobial, anticancer, and antimalarial agents

Plant Bioactives in the Treatment of Inflammation of Skeletal Muscles: A Molecular Perspective

In-silico investigation and drug likeliness studies of benzimidazole congeners: the new face of innovation

Exploring the phytochemistry, pharmacognostic properties, and pharmacological activities of medically important plant Momordica charantia

 

Dr. ANANDARUP GOSWAMI| Drug Discovery and Developmenty|Best Researcher Award

Dr. ANANDARUP GOSWAMI| Drug Discovery and Development|Best Researcher Award

Dr. ANANDARUP GOSWAMI at Vignan’s Foundation for Science, Technology and Research,India

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Dr. Anandarup Goswami’s passion for chemistry was ignited during his early years of education. He completed his undergraduate studies with a B.Sc. (Hons.) in Chemistry from the prestigious Presidency University in Kolkata, one of India’s top institutions for the sciences. He further honed his expertise by pursuing an M.Sc. in Chemistry at the renowned Indian Institute of Technology (IIT) Kanpur, known for producing some of the finest scientific minds in the country. Dr. Goswami’s dedication to his academic pursuits earned him a place in Cornell University, USA, where he completed his Ph.D. His doctoral work marked the beginning of his contribution to cutting-edge research, where he specialized in advanced areas of chemistry. His journey did not stop there; he went on to complete his postdoctoral research at Rutgers University, USA, and Palacky University, Czech Republic, enhancing his research portfolio and gaining exposure to diverse scientific methodologies and innovative research techniques.

Professional Endeavors 🧪

Dr. Anandarup Goswami joined Vignan’s Foundation for Science, Technology and Research (VFSTR) as an Associate Professor in November 2026. His professional career spans a broad spectrum of roles, from teaching and mentoring students to leading groundbreaking research. He has served as a Ph.D. supervisor and has guided numerous students in drug degradation studies and nanocatalysis development for environmental applications. His work at VFSTR has helped shape the future of young scientists while driving forward critical research in sustainable chemistry.

Dr. Goswami also holds numerous editorial appointments, including being a member of the Editorial Board of Current Indian Science (Bentham) and a Review Editor for Green and Sustainable Chemistry (Frontiers). His contributions to these roles highlight his prominence in the scientific community, where he is trusted to review and oversee publications in these significant areas of research.

Contributions and Research Focus 🔬

Dr. Goswami’s research contributions are primarily centered around two critical areas: pharmaceutically relevant compounds and sustainable nanocatalysts. His extensive work in the isolation and in-depth characterization of degradation products of pharmaceutical compounds has significant implications for drug safety, efficacy, and regulatory science. In tandem, his pioneering work on the development of nanocatalysts for environmental applications addresses pressing issues related to sustainability and environmental protection.

Dr. Goswami’s work emphasizes catalysis, energy conversion, and material science, offering solutions to some of today’s most critical challenges. His contributions span more than 50 peer-reviewed publications, including in highly reputed journals such as Journal of the American Chemical Society (JACS), Angewandte Chemie, and Nature Chemistry. Moreover, his book, Solvent-Free Methods in Nanocatalysis: From Catalyst Design to Applications, co-edited with prominent scientists, reflects his authority in the field of nanocatalysis.

Accolades and Recognition 🏆

Dr. Goswami’s research accomplishments have been widely recognized in the scientific community. With an h-index of 27 on Google Scholar and 26 on Scopus, along with more than 8,800 citations, his work has made a lasting impact on his field. He has received recognition for his contributions to nanocatalysis and drug degradation, and his research has gained international acclaim.

One of his notable patents, US010722743B2, titled Multicatalyst Polyelectrolyte Membranes and Methods of Utilizing the Same, was developed during his time at Rutgers University, USA. This patent reflects his innovative approach to solving complex problems in material science and catalysis.

Dr. Goswami’s contributions have also led him to collaborate with renowned scientists globally, including Prof. Tewodros Asefa from Rutgers University, USA, and Prof. Radek Zboril from RCPTM, Czech Republic. These collaborations have expanded his research’s scope and influence, enabling him to contribute to international advancements in chemistry.

🎓Publication 

Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis

  • Authors   : Manoj B Gawande, Anandarup Goswami, François-Xavier Felpin, Tewodros Asefa, Xiaoxi Huang, Rafael Silva, Xiaoxin Zou, Radek Zboril, Rajender S Varma
  • Journal    :Chemical reviews
  • Year         :2016

obalt‐Embedded Nitrogen‐Rich Carbon Nanotubes Efficiently Catalyze Hydrogen Evolution Reaction at All pH Values

  • Authors   : Xiaoxin Zou, Xiaoxi Huang, Anandarup Goswami, Rafael Silva, Bhaskar R Sathe, Eliška Mikmeková, Tewodros Asefa
  • Journal    :Angewandte Chemie International Edition
  • Year         :2014

Core–shell nanoparticles: synthesis and applications in catalysis and electrocatalysis

  • Authors   : Manoj B Gawande, Anandarup Goswami, Tewodros Asefa, Huizhang Guo, Ankush V Biradar, Dong-Liang Peng, Radek Zboril, Rajender S Varma
  • Journal    :Chemical Society Reviews
  • Year         :2015

Covalent functionalization of monolayered transition metal dichalcogenides by phase engineering

  • Authors   : Damien Voiry, Anandarup Goswami, Rajesh Kappera, Cecilia de Carvalho Castro e Silva, Daniel Kaplan, Takeshi Fujita, Mingwei Chen, Tewodros Asefa, Manish Chhowalla
  • Journal    :Nature chemistry
  • Year         :2015

Covalent functionalization of monolayered transition metal dichalcogenides by phase engineering

  • Authors   :Damien Voiry, Anandarup Goswami, Rajesh Kappera, Cecilia de Carvalho Castro e Silva, Daniel Kaplan, Takeshi Fujita, Mingwei Chen, Tewodros Asefa, Manish Chhowalla
  • Journal    :Nature Publishing Group
  • Year         :2015